Literature DB >> 15637079

Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.

Che-Chang Chang1, Ding-Yen Lin, Hsin-I Fang, Ruey-Hwa Chen, Hsiu-Ming Shih.   

Abstract

Daxx has been shown to function as an apoptosis regulator and transcriptional repressor via its interaction with various cytoplasmic and nuclear proteins. Here, we showed that Daxx interacts with Smad4 and represses its transcriptional activity via the C-terminal domain of Daxx. In vitro and in vivo interaction studies indicated that the binding of Smad4 to Daxx depends on Smad4 sumoylation. Substitution of Smad4 SUMO conjugation residue lysine 159, but not 113, to arginine not only disrupted Smad4-Daxx interaction but also relieved Daxx-elicited repression of Smad4 transcriptional activity. Furthermore, chromatin immunoprecipitation analyses revealed the recruitment of Daxx to an endogenous, Smad4-targeted promoter in a Lys(159) sumoylation-dependent manner. Finally, down-regulation of Daxx expression by RNA interference enhanced transforming growth factor beta-induced transcription of reporter and endogenous genes through a Smad4-dependent, but not K159R-Smad4-dependent, manner. Together, these results indicate that Daxx suppresses Smad4-mediated transcriptional activity by direct interaction with the sumoylated Smad4 and identify a novel role of Daxx in regulating transforming growth factor beta signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637079     DOI: 10.1074/jbc.M409161200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  DAXX is a new AIRE-interacting protein.

Authors:  Alessandra Meloni; Allesandra Meloni; Edoardo Fiorillo; Denise Corda; Federica Incani; Maria Luisa Serra; Antonella Contini; Antonio Cao; Maria Cristina Rosatelli
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

Review 2.  Emerging roles of SUMO modification in arthritis.

Authors:  Dongyao Yan; Francesca J Davis; Andrew D Sharrocks; Hee-Jeong Im
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

3.  Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression.

Authors:  Ryan T Saffert; Robert F Kalejta
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 4.  Role of Smad signaling in kidney disease.

Authors:  Yanhua Zhang; Songyan Wang; Shengmao Liu; Chunguang Li; Ji Wang
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

Review 5.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

6.  Death domain-associated protein 6 (Daxx) selectively represses IL-6 transcription through histone deacetylase 1 (HDAC1)-mediated histone deacetylation in macrophages.

Authors:  Zhenyu Yao; Qian Zhang; Xia Li; Dezhi Zhao; Yiqi Liu; Kai Zhao; Yin Liu; Chunmei Wang; Minghong Jiang; Nan Li; Xuetao Cao
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

7.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

Review 8.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

9.  Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.

Authors:  Wei-Wei Pan; Jian-Jie Zhou; Xiao-Man Liu; Ying Xu; Lian-Jun Guo; Chao Yu; Qing-Hua Shi; Heng-Yu Fan
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

10.  Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.

Authors:  Nils Wethkamp; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.